The peptide stack guide.

The most-studied recovery pairing in the research literature. BPC-157 is investigated for localized tissue and gut-lining repair, while TB-500 (a Thymosin Beta-4 fragment) is studied for systemic cell migration and angiogenesis. The two are combined in recovery research precisely because their mechanisms are complementary rather than redundant — a frequent-dose local agent alongside a longer-acting systemic one.

Typical duration

4–8 weeks

Est. reagent cost

$25–$55 / wk

Compounds

2

The most-studied growth-hormone secretagogue combination. CJC-1295 is a GHRH analog that raises the baseline of GH release, while Ipamorelin is a selective ghrelin-receptor agonist that produces a clean GH pulse with minimal effect on cortisol or prolactin. Research designs pair them so a sustained GHRH signal and a discrete pulsatile signal arrive together — the two arms of the GH axis at once. The pre-blended CJC-1295/Ipamorelin vial in our catalog reconstitutes as a single combined-mass solution.

Typical duration

8–12 weeks

Est. reagent cost

$20–$40 / wk

Compounds

1

Pairs the most-studied GLP-1 receptor agonist with a gut-lining repair agent. Semaglutide is researched on a slow weekly titration schedule, and BPC-157 is investigated alongside it in metabolic research for its studied role in gastrointestinal-lining integrity. The combination reflects a research interest in offsetting the GI burden seen in GLP-1 study designs while the titration ramps.

Typical duration

12+ weeks (titration-driven)

Est. reagent cost

$30–$60 / wk

Compounds

2

Tirzepatide is a dual GIP/GLP-1 receptor agonist with a rapidly growing research base, run on a multi-step weekly titration. AOD-9604 is a modified HGH fragment (176–191) studied in metabolic research. The pairing reflects research interest in combining incretin-receptor signaling with a separate metabolic fragment, each on its own cadence.

Typical duration

12+ weeks (titration-driven)

Est. reagent cost

$45–$85 / wk

Compounds

2

Two of the most-discussed compounds in cellular-aging research. NAD+ is studied for its central role in cellular energy metabolism and is the most thermally fragile compound in our catalog. GHK-Cu is a copper-binding tripeptide investigated in skin- and longevity-research contexts; its reconstituted solution is characteristically blue, and loss of that color signals degradation. The pairing reflects a research interest in combining a coenzyme-pathway agent with a copper-peptide repair agent.

Typical duration

4–6 weeks

Est. reagent cost

$35–$70 / wk

Compounds

2

The two synthetic neuropeptides are studied together so often they are effectively a single research pairing. Selank is investigated for anxiolytic effects, Semax for nootropic and neurotrophic effects, and research designs combine them for a balanced cognitive profile. Both are frequently reconstituted at higher concentration for intranasal delivery, which changes the reconstitution math — confirm your delivery method before calculating.

Typical duration

2–4 weeks

Est. reagent cost

$20–$45 / wk

Compounds

2

Tesamorelin is a stabilized GHRH analog studied for the growth-hormone axis at larger doses than the secretagogue blends. Paired with BPC-157, the protocol reflects research interest in running a GH-axis agent alongside a dedicated tissue-repair agent — a sustained hormonal-axis signal plus a frequent-dose local repair compound.

Typical duration

8–12 weeks

Est. reagent cost

$40–$75 / wk

Compounds

2

Ipamorelin is a selective growth-hormone secretagogue that produces a clean GH pulse without the GHRH-analog component, making it the lighter-touch option for the GH arm of a recovery protocol. Paired with TB-500’s systemic cell-migration research, this stack reflects interest in a discrete pulsatile GH signal alongside a longer-acting systemic repair agent.

Typical duration

6–10 weeks

Est. reagent cost

$25–$55 / wk

Compounds

2